- Home
- SUPN vs MCRI Comparison
SUPN vs MCRI Comparison
Compare SUPN & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- MCRI
- Stock Information
- Founded
- SUPN 2005
- MCRI 1972
- Country
- SUPN United States
- MCRI United States
- Employees
- SUPN N/A
- MCRI N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- MCRI Hotels/Resorts
- Sector
- SUPN Health Care
- MCRI Consumer Discretionary
- Exchange
- SUPN Nasdaq
- MCRI Nasdaq
- Market Cap
- SUPN 1.7B
- MCRI 1.5B
- IPO Year
- SUPN 2012
- MCRI 1993
- Fundamental
- Price
- SUPN $30.76
- MCRI $75.63
- Analyst Decision
- SUPN Hold
- MCRI Hold
- Analyst Count
- SUPN 2
- MCRI 5
- Target Price
- SUPN $36.00
- MCRI $87.20
- AVG Volume (30 Days)
- SUPN 647.0K
- MCRI 110.3K
- Earning Date
- SUPN 05-07-2025
- MCRI 04-22-2025
- Dividend Yield
- SUPN N/A
- MCRI 1.60%
- EPS Growth
- SUPN 6500.00
- MCRI N/A
- EPS
- SUPN 1.32
- MCRI 3.84
- Revenue
- SUPN $661,817,000.00
- MCRI $522,186,000.00
- Revenue This Year
- SUPN N/A
- MCRI $3.88
- Revenue Next Year
- SUPN $9.32
- MCRI $2.76
- P/E Ratio
- SUPN $23.30
- MCRI $19.70
- Revenue Growth
- SUPN 8.94
- MCRI 4.13
- 52 Week Low
- SUPN $25.53
- MCRI $64.50
- 52 Week High
- SUPN $40.28
- MCRI $96.11
- Technical
- Relative Strength Index (RSI)
- SUPN 40.39
- MCRI 41.75
- Support Level
- SUPN $29.77
- MCRI $69.99
- Resistance Level
- SUPN $34.26
- MCRI $76.34
- Average True Range (ATR)
- SUPN 1.51
- MCRI 3.35
- MACD
- SUPN -0.04
- MCRI 0.26
- Stochastic Oscillator
- SUPN 22.05
- MCRI 50.77
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.